A novel homozygous insertion and review of published mutations in the NNT gene causing familial glucocorticoid deficiency (FGD).

Autor: Jazayeri O; University of Groningen, University Medical Center Groningen, Department of Genetics, Groningen, The Netherlands., Liu X; BGI-Shenzhen, Shenzhen 518083, China., van Diemen CC; University of Groningen, University Medical Center Groningen, Department of Genetics, Groningen, The Netherlands., Bakker-van Waarde WM; University of Groningen, University Medical Center Groningen, Beatrix Children's Hospital, Department of Pediatric Endocrinology, The Netherlands., Sikkema-Raddatz B; University of Groningen, University Medical Center Groningen, Department of Genetics, Groningen, The Netherlands., Sinke RJ; University of Groningen, University Medical Center Groningen, Department of Genetics, Groningen, The Netherlands., Zhang J; BGI-Shenzhen, Shenzhen 518083, China., van Ravenswaaij-Arts CM; University of Groningen, University Medical Center Groningen, Department of Genetics, Groningen, The Netherlands. Electronic address: c.m.a.van.ravenswaaij@umcg.nl.
Jazyk: angličtina
Zdroj: European journal of medical genetics [Eur J Med Genet] 2015 Dec; Vol. 58 (12), pp. 642-9. Date of Electronic Publication: 2015 Nov 06.
DOI: 10.1016/j.ejmg.2015.11.001
Abstrakt: Familial glucocorticoid deficiency (FGD) is an autosomal recessive disorder characterized by low levels of cortisol despite high adrenocorticotropin (ACTH) levels, due to the reduced ability of the adrenal cortex to produce cortisol in response to stimulation by ACTH. FGD is a heterogeneous disorder for which causal mutations have been identified in MC2R, MRAP, MCM4 and TXNRD2. Also mutations in STAR and CYP11A1 can sometimes present with a phenotype resembling FGD. Recently, it has been indicated that FGD can also be caused by mutations in NNT (nicotinamide nucleotide transhydrogenase). We identified a 6.67 Mb homozygous region harboring the NNT gene by SNP haplotyping in a 1-year old Dutch boy presenting with FGD, but without mutations in MC2R and MRAP. Exome-sequencing revealed a novel homozygous mutation (NM_012343.3: c.1259dupG) in NNT that was predicted to be disease-causing. The mutation is located in exon 9 and creates a frameshift leading to a premature stop-codon (p.His421Serfs*4) that is known to result in FGD. Both parents were shown to be heterozygous carriers. We reviewed the literature for all the reported NNT mutations and their clinical presentation. The median age of disease onset in 23 reported patients, including the present patient, was 12 months (range 3 days-39 months). There was no difference in age of disease onset between truncating and non-truncating NNT mutations. Based on recent literature, we advise to monitor patients with FGD due to NNT mutations for possible combined mineralocorticoid insufficiency and extra-adrenal manifestations.
(Copyright © 2015 Elsevier Masson SAS. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: